TRIA, an architectural firm based in Boston, has recently announced the completion of Korro Bio’s new headquarters located in Cambridge, MA. This impressive project spans 50,000 square feet and serves as a significant milestone for the biopharmaceutical company focused on developing RNA-based genetic medicines. The project was completed ahead of schedule and under budget.
Korro Bio is known for its innovative approach to developing therapies for patients with rare and prevalent diseases. As such, they were seeking a space that would reflect their mission while accommodating their growth. TRIA delivered by creating open and flexible work environments along with dynamic meeting hubs and lab spaces designed to foster creativity and scientific discovery.
According to Amanda Roderman, project manager at TRIA: “This collaboration between Korro Bio’s leadership team and our design team was fantastic.” She went on to say that their goal was not only to create an environment that reflects Korro Bio’s cutting-edge work but also provides employees with a comfortable place where they can thrive.
Overall, this successful fit-out demonstrates TRIA’s ability to deliver exceptional results while staying true to their client’s vision.
